Stocktoria
Azenta, Inc. AZTA
Azenta, Inc. (AZTA) earns a Piotroski F-score of 6/9 (mixed financial health), with an Altman Z″ in the safe zone. It pays a dividend yielding 0.64% (safety: no dividend). FY2025 revenue was $593.8M at a -9.4% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Analyst price target
Wall Street analyst consensus — a sentiment gauge, not our scoring.
Smart money · insiders, last 12 months
Open-market insider purchases minus sells (SEC Form 4) — real buying with their own money is a bullish “smart money” signal; grants and option exercises are excluded.
How it ranks in Manufacturing · percentile among 1957 companies
Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 6/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · safe zone
| Component | Value |
|---|---|
| Working capital / assets | 0.229 |
| Retained earnings / assets | 0.689 |
| EBIT / assets | -0.013 |
| Equity / liabilities | 5.192 |
Sector peers · similar-size Manufacturing companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| AZTA | Azenta, Inc. | 6/9 | 9.11 | — | +3.6% |
| VECO | VEECO INSTRUMENTS INC | 6/9 | 4.55 | 129.7 | -7.4% |
| CRCT | Cricut, Inc. | 6/9 | 5.8 | 12.7 | -0.5% |
| ACLS | AXCELIS TECHNOLOGIES INC | 4/9 | 8.71 | 44.3 | -17.6% |
| ACMR | ACM Research, Inc. | 3/9 | 6.67 | 76.8 | +15.2% |
| ERII | Energy Recovery, Inc. | 5/9 | 15.7 | 19.8 | -6.9% |
| ASYS | AMTECH SYSTEMS INC | 3/9 | -0.5 | — | -21.6% |
About Azenta, Inc.
Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences industry in the United States, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. It operates through Sample Management Solutions and Multiomics segments. The Sample Management Solutions segment provides sample management products and services, including automated stores, cryogenic systems, automated sample tubes, consumables and instruments, and controlled rate thawing devices, as well as sample repository services. This segment also offers consultation services to clients throughout their experimental design and implementation processes. The Multiomics segment provides genomic and other sample analysis services comprising gene sequencing, gene synthesis, and related services. The company has a strategic partnership with Frontier Space Ltd to conduct scientific experiments in space. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Burlington, Massachusetts.
FAQ
Is AZTA financially healthy?
Azenta, Inc.'s Piotroski F-score is 6/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the safe zone.
Does AZTA pay a dividend, and is it safe?
Yes. Azenta, Inc. pays a dividend yielding about 0.64% with a None payout ratio, rated “no dividend” for safety.
How profitable is AZTA?
In FY2025, Azenta, Inc. had a net margin of -9.4% and a return on equity of -3.2%.
Is AZTA overvalued or undervalued?
Azenta, Inc. trades at about 1.2× trailing earnings — below its 10-year norm (10-year range 1.6×–78.2×, median 26.8×). Stocktoria reports the data, not buy/sell advice.
What is the analyst price target for AZTA?
The average Wall-Street price target for Azenta, Inc. is $26.20, about 21.9% below the recent price, from 5 analysts.
Is AZTA a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on Azenta, Inc.: a Piotroski F-score of 6/9, an Altman Z″ in the safe zone, a dividend yield of 0.64%. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-09-30. Facts plus Stocktoria's own computed scores — not investment advice.